2023-10-13 18:20:00
A new nanostructure has been developed that could revolutionize the treatment of age-related macular degeneration (AMD) and other vision problems. Researchers at Anglia Ruskin University (ARU) in Cambridge, England have successfully cultivated retinal pigment epithelium (RPE) cells, which are crucial for maintaining healthy vision.
AMD is a leading cause of blindness in the developed world, with the number of cases expected to rise due to the aging population. The deterioration of vision in AMD is primarily caused by lipid deposits known as drusen. Replacing damaged RPE cells has been identified as one of the most promising treatment options for the disease.
Led by Barbara Pierscionek, the team at ARU has been working on growing RPE cells for a considerable period. In a recent publication in the specialist magazine Materials & Design, the researchers unveiled their breakthrough method, which utilizes nanotechnology to create a 3D scaffold for the cells to grow and remain healthy for up to five months.
The structure was produced using an electrospinning technique, with the scaffold then treated with fluocinolone acetonide, a steroid that enhances cell resistance, promotes eye cell growth, and prevents inflammation. This innovative approach has yielded impressive results, with the cells showing significant improvements in growth, differentiation, and functionality.
Traditionally, RPE cells were grown on flat surfaces, which did not accurately simulate their natural environment. However, the 3D scaffolds provided by the new technique have proven to be more biologically relevant, resulting in superior cell growth.
The potential impact of this research is immense. By successfully cultivating artificial RPE cells, innovative methods of treating AMD and other vision problems can be developed, potentially helping millions of people worldwide. The system developed by the ARU team shows promise as a replacement for Bruch’s membrane, a critical component of the eye affected by AMD.
Further studies and clinical trials will be needed to fully validate and implement this new treatment approach. Nevertheless, the nanofiber scaffold and the use of anti-inflammatory substances such as fluocinolone acetonide represent a significant advancement in the field of vision restoration.
This groundbreaking research has the potential to improve the quality of life for the millions of people affected by AMD and other vision problems. The future looks brighter for those facing the prospect of losing their sight, thanks to the dedication and innovation of scientists at Anglia Ruskin University.]
#Nanotechnology #helps #grow #eye #cells